[HTML][HTML] The crucial regulatory role of type I interferon in inflammatory diseases

L Ji, T Li, H Chen, Y Yang, E Lu, J Liu, W Qiao, H Chen - Cell & Bioscience, 2023 - Springer
Abstract Type I interferon (IFN-I) plays crucial roles in the regulation of inflammation and it is
associated with various inflammatory diseases including systemic lupus erythematosus …

[HTML][HTML] Diagnosis and management of catastrophic antiphospholipid Syndrome and the potential impact of the 2023 ACR/EULAR antiphospholipid syndrome …

L Jacobs, N Wauters, Y Lablad, J Morelle, M Taghavi - Antibodies, 2024 - mdpi.com
Catastrophic antiphospholipid syndrome (CAPS) is a rare and life-threatening condition
characterized by the persistence of antiphospholipid antibodies and occurrence of multiple …

[HTML][HTML] Helios as a potential biomarker in systemic lupus erythematosus and new therapies based on immunosuppressive cells

A París-Muñoz, O León-Triana… - International Journal of …, 2023 - mdpi.com
The Helios protein (encoded by the IKZF2 gene) is a member of the Ikaros transcription
family and it has recently been proposed as a promising biomarker for systemic lupus …

Imatinib and M351-0056 enhance the function of VISTA and ameliorate the development of SLE via IFN-I and noncanonical NF-κB pathway

L Yang, T Zhang, P Wang, W Chen, W Liu, X He… - Cell Biology and …, 2023 - Springer
V-domain immunoglobulin suppressor of T-cell activation (VISTA), an important negative
checkpoint protein, participates in immunoregulation. Systemic lupus erythematosus (SLE) …

[HTML][HTML] Fish oil supplementation and risk of incident systemic lupus erythematosus: a large population-based prospective study

Y Chen, Z Li, Y Gao, B Xu, W Zhang, IXY Wu - Nutrition Journal, 2024 - Springer
Background Although fish oil has been considered to have an anti-inflammatory effect and
has been proven to play a beneficial role in the incidence of numerous diseases, the …

[HTML][HTML] Immunotherapy Strategy for Systemic Autoimmune Diseases: Betting on CAR-T Cells and Antibodies

V Chasov, E Zmievskaya, I Ganeeva, E Gilyazova… - Antibodies, 2024 - mdpi.com
Systemic autoimmune diseases (SAIDs), such as systemic lupus erythematosus (SLE),
systemic sclerosis (SSc) and rheumatoid arthritis (RA), are fully related to the unregulated …

Mesenchymal Stem Cells in Autoimmune Disease: A Systematic Review and Meta-Analysis of Pre-Clinical Studies

HN Swain, PD Boyce, BA Bromet, K Barozinksy… - Biochimie, 2024 - Elsevier
ABSTRACT Mesenchymal Stem Cells (MSCs) are of interest in the clinic because of their
immunomodulation capabilities, capacity to act upstream of inflammation, and ability to …

Mitochondrial aberrations in systemic lupus erythematosus pathogenesis: insights and therapeutic implications

H Li, L Zhou, W Zhou, X Zhang, J Shang… - Rheumatology & …, 2024 - Wiley Online Library
Systemic lupus erythematosus (SLE), a chronic autoimmune disease, is marked by impaired
immune tolerance and heightened activity in both innate and adaptive immune systems …

Roles of IRF4 in various immune cells in systemic lupus erythematosus

ZX Xiao, R Liang, N Olsen, SG Zheng - International Immunopharmacology, 2024 - Elsevier
Abstract Interferon regulatory factor 4 (IRF4) is a member of IRF family of transcription factors
which mainly regulates the transcription of IFN. IRF4 is restrictively expressed in immune …

State of the art: the treatment of systemic lupus erythematosus

G Costanzo, AG Ledda… - Current Opinion in Allergy …, 2024 - journals.lww.com
State of the art: the treatment of systemic lupus erythematosus Page 1 ACI 240411
CURRENT OPINION State of the art: the treatment of systemic lupus erythematosus Giulia …